2025-07-08T11:46:05-04:00 2024-12-31 251644159 BROWN PLUS 7420 HAYWARD ROAD SUITE 101 FREDERICK MD 21702 990 2024-01-01 521214782 IMMUNE DEFICIENCY FOUNDATION IMMU 4103216647 7550 TEAGUE ROAD SUITE 220 HANOVER MD 21706 JOREY BERRY PRESIDENT & CEO 4103216647 2025-06-26 true true WANDA K LYNN CPA P00726749 3016969449 2025-06-26 2024 2025-03-06 01:10:19Z JOREY BERRY 7550 TEAGUE ROAD SUITE 220 HANOVER MD 21076 20872042 false X WWW.PRIMARYIMMUNE.ORG X 1980 DE THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF PEOPLE AFFECTED BY PRIMARY IMMUNODEFICIENCY THROUGH FOSTERING A COMMUNITY EMPOWERED BY ADVOCACY, EDUCATION, AND RESEARCH. 12 12 53 698 0 8657179 9567648 13090 15870 315588 548184 0 8985857 10131702 244104 564056 0 4417931 4787765 0 1074601 2740219 4260977 7402254 9612798 1583603 518904 17355217 18802131 1438468 1362276 15916749 17439855 X THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE FOR EVERY PERSON AFFECTED BY PRIMARY IMMUNODEFICIENCY. WE FOSTER A COMMUNITY THAT IS CONNECTED, ENGAGED, AND EMPOWERED THROUGH ADVOCACY, EDUCATION, AND RESEARCH. false false 4918677 318142 IMMUNE DEFICIENCY FOUNDATION (IDF) PROVIDED EDUCATIONAL PROGRAMS AND SERVICES FOR PATIENTS AND FAMILIES LIVING WITH PRIMARY IMMUNODEFICIENCIES (PI). IN 2024, APPROXIMATELY 30,700 INDIVIDUALS WERE PROVIDED WITH EDUCATION AND SUPPORT THROUGH PUBLICATIONS, WEBINARS, VIDEOS AND PODCAST EPISODES, IDF GET CONNECTED GROUP MEETINGS, TEEN AND YOUNG ADULT ACTIVITIES AND THE IDF PI CONFERENCE. THERE WERE 997 ATTENDEES AT THE PI CONFERENCE (THE FIRST IN-PERSON PI CONFERENCE SINCE 2019), WHERE IDF DEBUTED OUR DOCUMENTARY, "COMPROMISED: LIFE WITHOUT IMMUNITY". IDF PROVIDED MORE THAN 265 HOTEL ROOM AND FLIGHT SCHOLARSHIPS FOR PI CONFERENCE ATTENDEES. MORE THAN 1.3 MILLION IDF WEBSITE SESSIONS WERE ACCESSED FOR INFORMATION, EVENTS, PODCASTS AND SUPPORT AND MORE THAN 625 IMMUNE SYSTEM SELF- ASSESSMENTS WERE SUBMITTED VIA THE WEBSITE. 1143977 THE PI COMMUNITY TURNS TO IDF FOR INDIVIDUAL ASSISTANCE INCLUDING BUT NOT LIMITED TO ANSWERING INSURANCE QUESTIONS, LOCATING A SPECIALIST IN THEIR AREA, FINDING TREATMENT INFORMATION, AND LEARNING MORE ABOUT THEIR DIAGNOSIS. IDF'S PATIENT ADVOCACY SPECIALISTS PROVIDED ANSWERS TO OVER 1,900 QUESTIONS ON 300 DIFFERENT TOPICS FROM INDIVIDUALS SEEKING EDUCATION, INFORMATION, AND ASSISTANCE. IDF ALSO WORKS AT THE FEDERAL AND STATE LEVELS TO EDUCATE LAWMAKERS AND THE PUBLIC ABOUT ISSUES THAT IMPACT THOSE WHO ARE IMMUNOCOMPROMISED. A STRONG VOLUNTEER GRASSROOTS ADVOCACY NETWORK, INCLUDING HEALTH ACCESS ADVOCATE VOLUNTEERS, INFORM POLICYMAKERS ABOUT ISSUES AFFECTING THOSE WITH PI. IN 2024, 850 INDIVIDUALS MET WITH AND SENT MORE THAN 2,700 LETTERS AND MESSAGES TO LEGISLATORS AND EXECUTIVE OFFICIALS TO ENSURE THAT PEOPLE WITH PI CAN LIVE HEALTHY AND PRODUCTIVE LIVES WITH EXCELLENT TREATMENT OPTIONS AND ACCESS TO THE MOST APPROPRIATE HEALTHCARE AVAILABLE. 1047079 245914 15800 TO IMPROVE THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF THOSE AFFECTED BY PI, IDF HAS SEVERAL INITIATIVES TO PROVIDE RESOURCES DIRECTLY TO THE MEDICAL COMMUNITY, INCLUDING EXHIBITING AT TEN MEDICAL CONFERENCES IN 2024, PROVIDING INFORMATION AND RESOURCES TO HEALTHCARE PROFESSIONALS, AND ADMINISTERING A CONSULTING IMMUNOLOGIST PROGRAM THAT ALLOWS CLINICIANS TO CONSULT WITH AN EXPERT CLINICAL IMMUNOLOGIST ABOUT PATIENT-SPECIFIC QUESTIONS TO OBTAIN VALUABLE DIAGNOSTIC, TREATMENT, AND DISEASE MANAGEMENT INFORMATION. IDF CONDUCTS NATIONAL SURVEYS AND FOCUS GROUPS OF PATIENTS, PHYSICIANS, AND OTHER HEALTHCARE PROFESSIONALS, BUILDING A COLLECTION OF QUANTIFIABLE DATA RELATED TO PRIMARY IMMUNODEFICIENCY. IN 2024, OVER 1,000 INDIVIDUALS PARTICIPATED IN AN IDF PATIENT SURVEY TO GATHER DATA ON IG TREATMENT. THERE WERE FOUR PUBLICATIONS IN 2024 USING USIDNET DATA. BECAUSE MEDICAL RESEARCH IS A PRIORITY, THE IDF RESEARCH GRANT PROGRAM FUNDED FOUR RESEARCH GRANTS FOR PI RELATED RESEARCH IN 2024, TOTALING OVER 159,000. 70 70 7109733 true true false true false false false false false true true false false false true false true false false false false false false false false false false true true true false false false false false false false false true false false false false false false false false true 19 0 true 53 true false false false false false false false false false false false false X 12 12 false false true false false false false true true false false true true true true true true true true false AL AK AR CA CO CT DE DC FL GA HI IL KS KY ME MD MA MI MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN VA WA WV WI X X X SARAH ROSE 4103216647 7550 TEAGUE ROAD HANOVER MD 21076 JOREY BERRY PRESIDENT & 40.00 X 291976 0 55291 AIMEE SIMPSON VP INSTITUTI 40.00 X 157876 0 20059 SARAH ROSE CFO 40.00 X 147965 0 24842 BRIAN LLOYD CTO 40.00 X 143863 0 28724 TAMMY BLACK VP COMMUNICA 40.00 X 151684 0 19050 LYNN ALBIZO VP PUBLIC PO 40.00 X 142625 0 22962 CHRISTOPHER DUCKETT DIRECTOR OF 40.00 X 126700 0 29637 JASON ANGELOS FINANCE CHAI 1.00 X 0 0 0 PETE ATHERTON FUTURES CHAI 1.00 X 0 0 0 COLLEEN DANSEREAU TRUSTEE 1.00 X 0 0 0 CHARLENE GRABOWSKI TRUSTEE 1.00 X 0 0 0 SETH KAUFMAN BOARD VICE C 1.00 X X 0 0 0 KATE SULLIVAN MD MAC CHAIR 1.00 X 0 0 0 ADRIAN MOLLO TRUSTEE 1.00 X 0 0 0 ANDY ROBINS TRUSTEE 1.00 X 0 0 0 STELLA SAFO TRUSTEE 1.00 X 0 0 0 TRACY A SHAW BOARD CHAIR 1.00 X X 0 0 0 SONIA VOHNOUT BOARD SECRET 1.00 X X 0 0 0 PETER WANG TRUSTEE 1.00 X 0 0 0 1162689 200565 9 false true false IMS TECHNOLOGY SERVICES INC 3055 MCCANN FARM DRIVE GARNET VALLEY PA 19060 CONSULTING 168093 FAEGRE DRINKER BIDDLE & REATH LLP PO BOX 536777 PITTSBURGH PA 15253 PUBLIC POLICY 166920 THE MT ROYAL PRINTING COMPANY 6310 BLAIR HILL LN BALTIMORE MD 21209 CONSULTING 133728 NEVINS & ASSOCIATES 215 WASHINGTON AVENUE SUITE 100 TOWSON MD 21204 CONSULTING 108995 4 15072 9552576 25276 9567648 SURVEY INCOME 541700 15800 15800 OTHER INCOME 541900 70 70 15870 551898 551898 10736626 10740340 -3714 -3714 -3714 10131702 15870 548184 231936 231936 332120 332120 520074 262914 223047 34113 3455322 2248235 698756 508331 118438 71456 31977 15005 399742 240184 109785 49773 294189 188372 63904 41913 24983 23207 632 1144 25340 23538 641 1161 230600 230600 71539 71539 493107 441651 18309 33147 96089 84512 3146 8431 115003 61634 36008 17361 176313 163777 4461 8075 103489 69994 20194 13301 373537 324713 23902 24922 1750630 1573383 21457 155790 143768 108436 20541 14791 39610 29404 5585 4621 DUES & SUBSCRIPTIONS 218329 158311 35050 24968 BANK FEES 177280 115915 30124 31241 PRINTING & COPYING 98013 51282 312 46419 POSTAGE & SHIPPING 85957 48363 1457 36137 37390 25796 7637 3957 9612798 7109733 1428464 1074601 1346127 1395606 2374122 2942049 79899 83166 18506 281164 218864 249760 62522 204524 187238 11924537 13010733 214663 114192 911675 850283 17355217 18802131 308172 298983 26695 1103601 1063293 1438468 1362276 X 14001757 16554151 1914992 885704 15916749 17439855 17355217 18802131 518904 1004202 X false true X true false X 6486028 9152968 8654145 8657179 9567648 42517968 6486028 9152968 8654145 8657179 9567648 42517968 18832052 23685916 194897 286433 299863 398737 551898 1731828 44249796 104316 0.53530 0.53520 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 148902 287034 435936 9176862 9612798 630640 157660 551181 546808 520113 630640 2248742 3373113 225131 364371 358010 435936 1383448 137795 136702 130028 157660 562185 843278 58108 174631 104284 148902 485925 7173807 1662429 8836236 6198759 975048 7173807 6183528 1114253 -1099022 6198759 5483828 699700 6183528 4962050 521778 5483828 1.00000 false false 213957 31972 181985 35803 30550 5253 187238 OPERATING LEASES 1038367 DEFERRED COMPENSATION 24926 1063293 11364365 1004202 300000 1304202 10060163 71539 71539 10131702 9841259 300000 300000 9541259 71539 71539 9612798 true THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10920 WILSHIRE BLVD SUITE 620 LOS ANGELES CA 90094 956006143 GOV 50000 RESEARCH CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVE NW WASHINGTON DC 20010 521640403 501C3 45500 RESEARCH BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501C3 39000 RESEARCH SEATTLE CHILDREN'S RESEARCH INSTITUTE PO BOX 5371 MS 818-FI SEATTLE WA 981455005 911156519 501C3 25000 RESEARCH THE REGENTS OF THE UNIVERSITY OF MINNESOTA 200 OAK STREET SE MINNEAPOLIS MN 55455 416007513 GOV 25000 RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICK ROAD STE N4327B BALTIMORE MD 21211 520595110 501C3 24161 RESEARCH CLINICAL IMMUNOLOGY SOCIETY 555 EAST WELLS STREET SUITE 1100 MILWAUKEE WI 532023823 521469030 501C3 15000 MEETING PARTICIPATIO 7 SCHOLARSHIPS 269 313817 RESEARCH STIPEND 1148 9253 HONORARIA 14 9050 SCHEDULE I, PAGE 1, PART I, LINE 2 EACH GRANT APPLICATION IS REVIEWED BY A COMMITTEE USING NIH SCORING CRITERIA. ONCE THE GRANT IS AWARDED, A 6-MONTH FINANCIAL AND PROGRESS REPORT IS DUE AS IS A 12-MONTH FINAL REPORT, WITH FINAL DELIVERABLES/ABSTRACT OR PUBLICATION DUE WITHIN 2 YEARS. X X X X false true false false false false false false false JOREY BERRY PRESIDENT & CEO 245156 46820 35276 20015 347267 AIMEE SIMPSON VP INSTITUTIONAL ADV 153492 4384 6290 13769 177935 SARAH ROSE CFO 143581 4384 6060 18782 172807 BRIAN LLOYD CTO 139589 4274 5860 22864 172587 TAMMY BLACK VP COMMUNICATIONS 147371 4313 5977 13073 170734 LYNN ALBIZO VP PUBLIC POLICY 138545 4080 5690 17272 165587 CHRISTOPHER DUCKETT DIRECTOR OF TALENT 122831 3869 5289 24348 156337 SCHEDULE J, PART III AT PRESENT, ONLY THE CEO PARTICIPATES IN THE NONQUALIFIED DEFERRED COMPENSATION PLAN. ELIGIBILITY MAY BE EXTENDED TO OTHER MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES. THE ELIGIBLE EMPLOYEE(S) WOULD BE DETERMINED BY THE BOARD OR A COMMITTEE OF THE BOARD IN CONJUNCTION WITH THE PRESIDENT/CEO. THE POTENTIAL CONTRIBUTION AMOUNT IS DETERMIEND JUST PRIOR TO EACH BUDGET YEAR BY THE BOARD/BOARD COMMITTEE AND VOTED ON WITHIN THE BUDGET APPROVAL. AT THE END OF THAT YEAR, THE BOARD OR COMMITTEE DETERMINES THE EXACT AMOUNT TO ALLOW AND THAT AMOUNT IS TRANSFERRED TO THE PARTICIPANT'S ACCOUNT SHORTLY THEREAFTER. X 2 23147 QUOTED MARKET PRICE X 1 329 FAIR MARKET VALUE X GIFT CARDS 18 1800 FAIR MARKET VALUE false true false FORM 990 - ORGANIZATION'S MISSION THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE FOR EVERY PERSON AFFECTED BY PRIMARY IMMUNODEFICIENCY. WE FOSTER A COMMUNITY THAT IS CONNECTED, ENGAGED, AND EMPOWERED THROUGH ADVOCACY, EDUCATION, AND RESEARCH. FORM 990, PAGE 2, PART III, LINE 4A IMMUNE DEFICIENCY FOUNDATION (IDF) PROVIDED EDUCATIONAL PROGRAMS AND SERVICES FOR PATIENTS AND FAMILIES LIVING WITH PRIMARY IMMUNODEFICIENCIES (PI). IN 2024, APPROXIMATELY 30,700 INDIVIDUALS WERE PROVIDED WITH EDUCATION AND SUPPORT THROUGH PUBLICATIONS, WEBINARS, VIDEOS AND PODCAST EPISODES, IDF GET CONNECTED GROUP MEETINGS, TEEN AND YOUNG ADULT ACTIVITIES AND THE IDF PI CONFERENCE. THERE WERE 997 ATTENDEES AT THE PI CONFERENCE (THE FIRST IN-PERSON PI CONFERENCE SINCE 2019), WHERE IDF DEBUTED OUR DOCUMENTARY, "COMPROMISED: LIFE WITHOUT IMMUNITY". IDF PROVIDED MORE THAN 265 HOTEL ROOM AND FLIGHT SCHOLARSHIPS FOR PI CONFERENCE ATTENDEES. MORE THAN 1.3 MILLION IDF WEBSITE SESSIONS WERE ACCESSED FOR INFORMATION, EVENTS, PODCASTS AND SUPPORT AND MORE THAN 625 IMMUNE SYSTEM SELF- ASSESSMENTS WERE SUBMITTED VIA THE WEBSITE. FORM 990, PAGE 2, PART III, LINE 4B THE PI COMMUNITY TURNS TO IDF FOR INDIVIDUAL ASSISTANCE INCLUDING BUT NOT LIMITED TO ANSWERING INSURANCE QUESTIONS, LOCATING A SPECIALIST IN THEIR AREA, FINDING TREATMENT INFORMATION, AND LEARNING MORE ABOUT THEIR DIAGNOSIS. IDF'S PATIENT ADVOCACY SPECIALISTS PROVIDED ANSWERS TO OVER 1,900 QUESTIONS ON 300 DIFFERENT TOPICS FROM INDIVIDUALS SEEKING EDUCATION, INFORMATION, AND ASSISTANCE. IDF ALSO WORKS AT THE FEDERAL AND STATE LEVELS TO EDUCATE LAWMAKERS AND THE PUBLIC ABOUT ISSUES THAT IMPACT THOSE WHO ARE IMMUNOCOMPROMISED. A STRONG VOLUNTEER GRASSROOTS ADVOCACY NETWORK, INCLUDING HEALTH ACCESS ADVOCATE VOLUNTEERS, INFORM POLICYMAKERS ABOUT ISSUES AFFECTING THOSE WITH PI. IN 2024, 850 INDIVIDUALS MET WITH AND SENT MORE THAN 2,700 LETTERS AND MESSAGES TO LEGISLATORS AND EXECUTIVE OFFICIALS TO ENSURE THAT PEOPLE WITH PI CAN LIVE HEALTHY AND PRODUCTIVE LIVES WITH EXCELLENT TREATMENT OPTIONS AND ACCESS TO THE MOST APPROPRIATE HEALTHCARE AVAILABLE. FORM 990, PAGE 2, PART III, LINE 4C TO IMPROVE THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF THOSE AFFECTED BY PI, IDF HAS SEVERAL INITIATIVES TO PROVIDE RESOURCES DIRECTLY TO THE MEDICAL COMMUNITY, INCLUDING EXHIBITING AT TEN MEDICAL CONFERENCES IN 2024, PROVIDING INFORMATION AND RESOURCES TO HEALTHCARE PROFESSIONALS, AND ADMINISTERING A CONSULTING IMMUNOLOGIST PROGRAM THAT ALLOWS CLINICIANS TO CONSULT WITH AN EXPERT CLINICAL IMMUNOLOGIST ABOUT PATIENT-SPECIFIC QUESTIONS TO OBTAIN VALUABLE DIAGNOSTIC, TREATMENT, AND DISEASE MANAGEMENT INFORMATION. IDF CONDUCTS NATIONAL SURVEYS AND FOCUS GROUPS OF PATIENTS, PHYSICIANS, AND OTHER HEALTHCARE PROFESSIONALS, BUILDING A COLLECTION OF QUANTIFIABLE DATA RELATED TO PRIMARY IMMUNODEFICIENCY. IN 2024, OVER 1,000 INDIVIDUALS PARTICIPATED IN AN IDF PATIENT SURVEY TO GATHER DATA ON IG TREATMENT. THERE WERE FOUR PUBLICATIONS IN 2024 USING USIDNET DATA. BECAUSE MEDICAL RESEARCH IS A PRIORITY, THE IDF RESEARCH GRANT PROGRAM FUNDED FOUR RESEARCH GRANTS FOR PI RELATED RESEARCH IN 2024, TOTALING OVER 159,000. FORM 990, PAGE 6, PART VI, LINE 4 THE ORGANIZATION'S BYLAWS WERE UPDATED IN 2024 FOR THE FOLLOWING: 1) ADDED RESPONSIBILITIES FOR EACH TRUSTEE TO ENSURE ADHERANCE TO BOARD GOVERNANCE PRINCIPLES AND AVOIDING CONFLICTS OF INTEREST. 2) CLARIFIED THAT PERSONS WHO HAVE A BUSINESS RELATIONSHIP WITH OR FINANCIAL INTEREST IN MEMBERS OF INDUSTRY ARE NOT ELIGIBLE TO BE TRUSTEES FORM 990, PAGE 6, PART VI, LINE 11B THE 990 IS REVIEWED BY THE CHIEF FINANCIAL OFFICER ONCE COMPLETED BY THE OUTSIDE CPA FIRM. ONCE THE CHIEF FINANCIAL OFFICER IS SATISFIED WITH THE ACCURACY, THE 990 IS THEN PASSED ON TO THE PRESIDENT & CEO FOR REVIEW. AFTER THAT LEVEL OF REVIEW IS COMPLETE, IT IS THEN PASSED ON TO THE FINANCE COMMITTEE FOR APPROVAL. ONCE THAT HAPPENS IT IS REVIEWED AND ONCE ACCURATE, APPROVED BY THE BOARD OF TRUSTEES. FORM 990, PAGE 6, PART VI, LINE 12C EACH YEAR IDF REQUESTS THAT ALL BOARD OF TRUSTEE MEMBERS AND STAFF COMPLETE A CONFLICT OF INTEREST STATEMENT DISCLOSING ANY POTENTIAL CONFLICT THAT MAY EXIST. THESE ARE KEPT ON FILE IN A DIGITAL FILE. THE BOARD LIAISON/HR DISTRIBUTES THE STATEMENT ANNUALLY FOR SIGNATURES TO THE BOARD. THE BOARD LIAISON/HR, WOULD DISTRIBUTE TO ANY STAFF NECESSARY. THE BOARD LIAISON/HR WOULD REVIEW AND WOULD BRING IT TO THE EXECUTIVE COMMITTEE AND BOARD OF TRUSTEES IF THERE ARE CONFLICTS. ANY RESTRICTIONS, IF NECESSARY, WOULD BE MADE AT THE BOARD OF TRUSTEE OR PRESIDENT/CEO LEVEL, DEPENDING ON WHO/WHAT THE CONFLICT IS. FORM 990, PAGE 6, PART VI, LINE 15A THE PRESIDENT & CEO'S COMPENSATION IS REVIEWED AND DOCUMENTED BY THE EXECUTIVE COMMITTEE. THE COMMITTEE REVIEWS WEBSITES SUCH AS SALARY.COM AND/OR REVIEWS OF MATERIALS SUCH AS ASAE'S COMPENSATION AND BENEFITS STUDY BOOK, OR THE NATIONAL HEALTH COUNCILS COMPENSATION STUDY TO DETERMINE THE CORRECT SALARY FOR THE POSITION. THE COMPENSATION IS PRESENTED AND APPROVED BY THE FULL BOARD. THE EXECUTIVE COMMITTEE INFORMS THE PRESIDENT & CEO, HUMAN RESOURCES, AND ACCOUNTING. FORM 990, PAGE 6, PART VI, LINE 15B FOR ALL KEY EMPLOYEES, AN ANNUAL REVIEW IS CONDUCTED BY THE EMPLOYEE'S SUPERVISOR. BASED ON THIS REVIEW, IT IS DETERMINED IF THE PERSON GETS AN ANNUAL INCREASE BEYOND THE COST OF LIVING (IF ANY ADJUSTMENT FOR COL IS GIVEN). REVIEW OF WEBSITES SUCH AS SALARY.COM AND/OR REVIEW OF MATERIALS SUCH AS ASAE'S COMPENSATION AND BENEFITS STUDY BOOK OR THE NATIONAL HEALTH COUNCILS COMPENSATION STUDY HELPS DETERMINE THE CORRECT SALARY FOR THE POSITION. IF THE SUPERVISOR APPROVES AN INCREASE, PAPERWORK IS DRAWN UP AND SUBMITTED TO THE PRESIDENT & CEO FOR APPROVAL. ONCE APPROVAL IS COMPLETE, HUMAN RESOURCES AND ACCOUNTING ARE INFORMED OF THE INCREASE. THE EMPLOYEE IS NOTIFIED AS WELL. FORM 990, PAGE 6, PART VI, LINE 17 KENTUCKY, MAINE, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MISSISSIPPI, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, NORTH DAKOTA, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN FORM 990, PAGE 6, PART VI, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE.